Eugenia Sacerdote de Lustig States to learn about the work of the professor Jonas Salk. When she returned to Argentina, she inoculated herself in public and did the same with her children to convince the population of the benefits of the polio vaccine. Since 1989, she investigated the role of free radicals and oxidative stress in living patients with Alzheimer's disease, vascular dementia and Parkinson's disease, expanding the basic knowledge of neurological diseases. Sacerdote de Lustig was a researcher at CONICET and head of virology at Instituto Malbrán. For more than 40 years, she studied tumor cells in the Instituto de Oncología Ángel H.
SAV001 a feasible option for an HIV vaccine. Indeed, Jonas Salk developed a therapeutic HIV vaccine in 1987, called Remune now being developed by Immune Response BioPharma, Inc., is based on the killed whole virus approach. Remune vaccine has completed over 25 clinical studies to date and showed a robust mechanism of action restoring white blood cell counts in CD4 & CD8 T cells by reducing viral load and increasing immunity. Also, a group of researchers and professionals in the field of HIV strongly advocates that the killed HIV approach must be taken to fight back the global HIV and AIDS